The FDA gives the green light to the first gene therapy for deafness
Rob SteinNPR News
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
Reported by NPR NewsRead original
Coverage from 1 source
Coverage by lean
- Unknown1
Comments
Loading comments…
Sign in to join the discussion.
Sign in with SpryLogin